Reagents

Nivolumab is a fully human monoclonal IgG4 antibody that is approved by the U.S.

Nivolumab is a fully human monoclonal IgG4 antibody that is approved by the U.S.

Obinutuzumab (Gazyva) is a humanized monoclonal antibody that is approved by the U.S.

Obinutuzumab (Gazyva) is a humanized monoclonal antibody that is approved by the U.S.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

Rituximab was approved for medical use in 1997. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Rituximab was approved for medical use in 1997. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Rituximab was approved for medical use in 1997. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.

Beta-actin is one of the six different actin isoforms that have been identified. The actin molecules found in cells of various species and tissues tend to be very similar in their immunological and physical properties.

The rabbit immune system generates antibody diversity and optimizes affinity. GenScript utilizes MonoRab&trade technology to generate the high affinity and specificity monoclonal rabbit antibodies.